IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 481 - 500 of 1136 stories.
May 8, 2012
LONZA ON TRACK TO MEET 2012 TARGETS Lonza, in its business update announcement for the first quarter of 2012, says that the company’s business performance was in line with...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-May-8_43278.html
May 8, 2012
DSM says that the performance of the company’s pharmaceutical business in the first quarter of 2012 remained weak, although first signs of improvement are visible. The...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/DSMs-Pharma-Business-Reports-Weak-Results-in-First-Quarter_43275.html
May 4, 2012
Lonza, in its business update announcement for the first quarter of 2012, says that the company’s business performance was in line with expectations in the quarter. Capacity...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-on-Track-to-Meet-2012-Targets-Arch-Integration-Progressing-Well_43219.html
May 4, 2012
Cambrex (East Rutherford, NJ) reported a more than doubling in net profits for the first quarter ended March 31, 2012, compared with the year-ago quarter, to $7 million. Net sales for...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-Reports-Rise-in-Profits-and-Sales_43220.html
May 1, 2012
Materia (Pasadena, CA), a catalyst firm with an exclusive license for Grubbs catalyst technology, has received a Phase II Fast Track Small Business Technology Transfer grant from the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Materia-Secures-NIH-Funding-to-Develop-Alternative-Reagents_43143.html
May 1, 2012
WATSON PHARMACEUTICALS TO ACQUIRE ACTAVIS FOR $5.6 BILLION Watson Pharmaceuticals (Parsippany, NJ), a leading manufacturer of generic, branded and biologic pharmaceutical products, and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-May-1_43141.html
May 1, 2012
GlaxoSmithKline (GSK; London) says it has formalized a collaboration with the University of Nottingham (Nottingham, U.K.), to establish a new laboratory to accommodate a centre of...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/GSK-and-University-of-Nottingham-to-Establish-Laboratory-for-Sustainable-Chemistry_43140.html
May 1, 2012
Aesica Pharmaceuticals (Newcastle upon Tyne, U.K.), a provider of active pharmaceutical ingredients (API), formulations, and custom synthesis, says Emma Mickley has been promoted from...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Aesica-Announces-New-Senior-Appointment-in-U-S-_43139.html
May 1, 2012
Amgen (Thousand Oaks, CA) says it has signed an agreement to acquire 95.6% stake in Mustafa Nevzat Pharmaceuticals (Istanbul, Turkey), a privately held pharmaceutical company, for...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Amgen-to-Acquire-a-Leading-Turkish-API-Producer_43136.html
April 26, 2012
DSM and Crucell (Leiden, the Netherlands), a biotech firm, have pulled the plug on all inhouse projects at their biosimilar drugs joint venture company Percivia (Cambridge, MA). Set up...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmaceuticals-DSM-Joint-Venture-Percivia-Ceases-Inhouse-Activities_43001.html
April 26, 2012
Watson Pharmaceuticals (Parsippany, NJ), a leading manufacturer of generic, branded and biologic pharmaceutical products, and privately held generic pharmaceuticals company Actavis...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Watson-Pharmaceuticals-to-Acquire-Actavis-for-$5-6-Billion_43002.html
April 25, 2012
Codexis (Redwood City, CA) says that the U.S. FDA has approved a new process co-developed by Codexis for the manufacture of sitagliptin, the active pharmaceutical ingredient (API) in...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-Approves-Process-Co-Developed-by-Codexis-to-Produce-Sitagliptin-API_42957.html
April 24, 2012
FDA STRENGTHENS INTERNATIONAL COLLABORATION TO ENSURE SAFETY OF IMPORTED PHARMA PRODUCTS The U.S. Food and Drug Administration (FDA) says it is taking several steps to ensure that...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-April-24_42924.html
April 24, 2012
The U.S. Food and Drug Administration (FDA) says it is taking several steps to ensure that imported drugs meet the same rigorous standards for safety and quality as those manufactured...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-Strengthens-International-Collaboration-to-ensure-Safety-of-Imported-Products_42923.html
April 24, 2012
W. R. Grace, in partnership with Formac Pharmaceuticals (Heverlee, Belgium), announced positive data from initial human studies of the companies' mesoporous silica-based drug delivery...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Grace-and-Formac-Announce-Positive-Data-from-Clinical-Trial-Demonstrating-Use-of-Silica-for-Drug-Delivery_42919.html
April 23, 2012
Pfizer says it has entered into an agreement to divest its nutrition business to Nestlé (Vevey, Switzerland) for $11.85 billion in cash. Pfizer’s nutrition business...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Nestle-to-Acquire-Pfizers-Nutrition-Business-for-$11-85-Billion_42887.html
April 23, 2012
The Chinese government says that the Ministry of Public Security (Beijing) has confiscated 77 million capsules made from toxic chromium-contained industrial gelatin. Earlier this...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Police-Confiscate-77-Million-Contaminated-Capsules-in-China_42891.html
April 19, 2012
Mylan (Canonsburg, PA) says it will invest €76 million/year ($100 million/year) over the next five years in the company’s operations at Dublin and Galway in Ireland. Mylan...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mylan-to-Invest-$500-Million-in-Ireland-Over-Next-Five-Years_42788.html
April 19, 2012
The answer to the question of whether there could be a revolution to bring about Quality by Design (QbD) in pharmaceutical manufacturing, unequivocally, is yes. But we need some...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Can-the-Combination-of-Creative-Destruction-and-Steve-Jobs-Traits-Lead-to-a-Pharma-QbD-Spring_42714.html
April 17, 2012
AMRI SIGNS DEVELOPMENT AND MANUFACTURING DEAL WITH AUSTRALIAN FIRM Albany Molecular Research Inc. (AMRI; Albany, NY) says it was selected by Biota (Melbourne Australia), a leading...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-April-17_42724.html
Pages: « Previous  16 17 18 19 20 21 22 23 24 [25] 26 27 28 29 30 31 32 33 34 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa